Terms: = Gastric cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Prognosis
17 results:
1. [Clinicopathological factors and clinical significance of No.12b lymph node metastasis in gastric antrum cancer].
Zhang B; Zheng GL; Zhang Y; Zhao Y; Zhu HT; Zhang T; Liu Y; Zheng ZC
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Feb; 27(2):167-174. PubMed ID: 38413085
[No Abstract] [Full Text] [Related]
2. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
Pyo JS; Kim NY; Min KW; Kang DW
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
[No Abstract] [Full Text] [Related]
3. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract] [Full Text] [Related]
4. LINC01094 Predicts Poor prognosis in Patients With gastric cancer and is Correlated With EMT and Macrophage Infiltration.
Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
[No Abstract] [Full Text] [Related]
5. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
Li D; Wang R; Wu N; Yu Y
Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058
[TBL] [Abstract] [Full Text] [Related]
6. Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer.
Kusunoki Y; Okugawa Y; Toiyama Y; Kusunoki K; Ichikawa T; Ide S; Shimura T; Kitajima T; Imaoka H; Fujikawa H; Yasuda H; Yokoe T; Okita Y; Mochiki I; Ohi M; McMillan DC; Nakatani K; Kusunoki M
Clin Nutr; 2021 May; 40(5):2640-2653. PubMed ID: 33933730
[TBL] [Abstract] [Full Text] [Related]
7. Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The cancer Genome Atlas cohort.
Sadato D; Ogawa M; Hirama C; Hishima T; Horiguchi SI; Harada Y; Shimoyama T; Itokawa M; Ohashi K; Oboki K
FEBS Open Bio; 2020 Mar; 10(3):455-467. PubMed ID: 31991047
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and clinicopathologic significance of MicroRNA-125a-5p in cancers: A meta-analysis.
Ye H; Zhu W; Mei L; Lu Z
Medicine (Baltimore); 2019 Aug; 98(31):e16685. PubMed ID: 31374052
[TBL] [Abstract] [Full Text] [Related]
10. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.
Seeruttun SR; Xu L; Wang F; Yi X; Fang C; Liu Z; Wang W; Zhou Z
Cancer Commun (Lond); 2019 Jun; 39(1):32. PubMed ID: 31182160
[TBL] [Abstract] [Full Text] [Related]
11. Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.
Huang H; Li J; Hu WJ; Chen MH; Chen SS; Chen C; Luo HQ; Zhou KY; Liu XG; Li XY
J BUON; 2018; 23(4):1185-1194. PubMed ID: 30358230
[TBL] [Abstract] [Full Text] [Related]
12. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients.
Song Y; Liu D; He G
Cancer Biomark; 2015; 15(5):591-7. PubMed ID: 26406948
[TBL] [Abstract] [Full Text] [Related]
13. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract] [Full Text] [Related]
14. Significance of thrombocytosis in clinicopathologic characteristics and prognosis of gastric cancer.
Li FX; Wei LJ; Zhang H; Li SX; Liu JT
Asian Pac J Cancer Prev; 2014; 15(16):6511-7. PubMed ID: 25169479
[TBL] [Abstract] [Full Text] [Related]
15. Differences in prognostic factors between early and advanced gastric cancer.
Kim BS; Cho SW; Min SK; Lee BH
Hepatogastroenterology; 2011; 58(107-108):1032-40. PubMed ID: 21830438
[TBL] [Abstract] [Full Text] [Related]
16. Early onset, multiple primary malignancies, and poor prognosis are indicative of an inherited predisposition to esophageal squamous cell carcinoma for the familial as opposed to the sporadic cases--an update on over 14-year survival.
Wen D; Wang S; Zhang L; Wei L; Zhou W; Peng Q
Eur J Med Genet; 2009; 52(6):381-5. PubMed ID: 19632364
[TBL] [Abstract] [Full Text] [Related]
17. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract] [Full Text] [Related]
